These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34982597)

  • 21. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
    Mohiuddin SG; Massahi A; Orman MA
    Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stochastic expression of lactate dehydrogenase A induces Escherichia coli persister formation.
    Yamamoto N; Isshiki R; Kawai Y; Tanaka D; Sekiguchi T; Matsumoto S; Tsuneda S
    J Biosci Bioeng; 2018 Jul; 126(1):30-37. PubMed ID: 29449156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species.
    Van Acker H; Sass A; Bazzini S; De Roy K; Udine C; Messiaen T; Riccardi G; Boon N; Nelis HJ; Mahenthiralingam E; Coenye T
    PLoS One; 2013; 8(3):e58943. PubMed ID: 23516582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RNA-Binding Protein ProQ Promotes Antibiotic Persistence in Salmonella.
    Rizvanovic A; Michaux C; Panza M; Iloglu Z; Helaine S; Wagner EGH; Holmqvist E
    mBio; 2022 Dec; 13(6):e0289122. PubMed ID: 36409088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular reprogramming and phenotype switching in
    Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060
    [No Abstract]   [Full Text] [Related]  

  • 29. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence.
    Luidalepp H; Jõers A; Kaldalu N; Tenson T
    J Bacteriol; 2011 Jul; 193(14):3598-605. PubMed ID: 21602347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host Cell Oxidative Stress Induces Dormant Staphylococcus aureus Persisters.
    Peyrusson F; Nguyen TK; Najdovski T; Van Bambeke F
    Microbiol Spectr; 2022 Feb; 10(1):e0231321. PubMed ID: 35196815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae.
    Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X
    J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Genes Involved in
    Li T; Wang J; Cao Q; Li F; Han J; Zhu B; Zhang Y; Niu H
    Front Cell Infect Microbiol; 2020; 10():581986. PubMed ID: 33117736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of TCA cycle enhances Staphylococcus aureus persister cell formation in stationary phase.
    Wang Y; Bojer MS; George SE; Wang Z; Jensen PR; Wolz C; Ingmer H
    Sci Rep; 2018 Jul; 8(1):10849. PubMed ID: 30022089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AldB controls persister formation in Escherichia coli depending on environmental stress.
    Kawai Y; Matsumoto S; Ling Y; Okuda S; Tsuneda S
    Microbiol Immunol; 2018 May; 62(5):299-309. PubMed ID: 29577369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics.
    Defraine V; Fauvart M; Michiels J
    Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
    Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G
    Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The formation of persister cells in stationary-phase cultures of Escherichia coli is associated with the aggregation of endogenous proteins.
    Leszczynska D; Matuszewska E; Kuczynska-Wisnik D; Furmanek-Blaszk B; Laskowska E
    PLoS One; 2013; 8(1):e54737. PubMed ID: 23358116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB.
    Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli.
    Dörr T; Vulić M; Lewis K
    PLoS Biol; 2010 Feb; 8(2):e1000317. PubMed ID: 20186264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.